Serve as a TIL cell therapy expert in Medical Affairs, educating providers and optimizing tumor tissue procurement.
Lead engagement with surgeons and cross-functional teams to support clinical trials and medical strategy.
Represent Iovance at professional meetings and contribute to publications and educational materials.
Iovance Biotherapeutics is a global leader in developing tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. It is an end-to-end cell therapy company with U.S.-based manufacturing and an inclusive culture.
Lead and manage the assigned clinical operations team, setting and executing departmental strategy.
Oversee clinical trial agreements, budgets, and the timely execution of clinical research programs from conception through final study report.
Maintain oversight of study conduct at sites, ensure adherence to protocols and GCP, and serve as company representative at external meetings.
Iovance Biotherapeutics is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. As an end-to-end cell therapy company with fully owned, centralized U.S.-based manufacturing, it operates with a fast-paced, collaborative culture focused on bringing first-in-class treatments to cancer patients.
Own integrated program strategy for TIL cell therapy assets across early-to-late-stage clinical development.
Chair cross-functional program teams, manage timelines, and translate strategy into execution.
Partner with senior leadership to advance programs from early studies to global regulatory submissions.
Iovance Biotherapeutics is a global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. The company operates as an end-to-end cell therapy company with fully owned, centralized U.S.-based manufacturing and is committed to a diverse and inclusive work environment.
Drive commercial growth by developing multi-year business plans and leading key oncology accounts.
Educate healthcare leaders on cell therapy logistics and resolve access barriers with cross-functional teams.
Serve as a field leader, coaching colleagues and ensuring compliance with all policies and regulations.
Iovance Biotherapeutics is a biotechnology company that develops and delivers tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. As the first company to commercialize TIL therapy, it operates a large-scale U.S. manufacturing facility and promotes a collaborative, patient-focused culture.
Provide strategic and operational leadership across multiple clinical programs, translating development strategy into strong execution.
Oversee clinical trial planning, budgets, CRO/vendor relationships, and cross-functional collaboration to ensure quality and accountability.
Lead and develop a small Clinical Operations team while remaining hands-on in a fast-paced biotech environment.
Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for cancer, neurologic, and autoimmune diseases. The company fosters an inclusive culture valuing curiosity, creativity, and shared accountability, empowering employees to drive breakthroughs.
Lead and scale the Clinical Operations function for MiraVi's ophthalmology programs.
Drive global clinical operations strategy, CRO/vendor oversight, and study execution from startup to close-out.
Partner with regulatory, CMC, quality, and finance to deliver compliant, on-time, on-budget trials.
MiraVi is an ophthalmology affiliate of Osanni focused on advancing treatments for dry age-related macular degeneration (AMD). The company is building a highly skilled, collaborative team dedicated to developing new medicines for patients.
Develop and execute U.S. stakeholder engagement strategies for advocacy and professional societies.
Build relationships with KOLs, patient advocacy groups, and oncology experts.
Lead regional oncology conferences and advocacy events for launch readiness.
Iovance Biotherapeutics is the global leader in developing and delivering tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. The company operates as an end-to-end cell therapy organization with U.S.-based manufacturing, serving cancer patients worldwide.
Lead ongoing clinical data review to ensure quality, interpretation, and patient safety across development programs.
Develop and review study protocols, investigator brochures, and regulatory documents in partnership with cross-functional teams.
Represent Clinical Development on study teams and present clinical data and scientific information to internal and external audiences.
Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company discovering, developing, and commercializing new medicines for cancer, neurologic, and autoimmune disease. They cultivate an inclusive culture valuing curiosity, creativity, and shared accountability, empowering individuals to challenge the unknown together.
Develop and implement global regulatory strategies for oncology programs from early development through post-marketing.
Lead preparation and submission of INDs, NDAs, and other regulatory filings to ensure compliance and quality.
Provide strategic regulatory guidance and cross-functional collaboration to drive program success.
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines for cancer, neurologic and autoimmune disease. They cultivate an inclusive culture that values curiosity, creativity, and shared accountability, empowering individuals to challenge the unknown together.
Leads the planning, execution, and delivery of complex global clinical studies, managing timelines, budgets, and quality.
Oversees CROs and external vendors, ensuring alignment with study timelines, budgets, and contractual obligations.
Drives cross-functional collaboration and communicates study progress, risks, and decisions to stakeholders.
Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for cancer, neurologic, and autoimmune diseases. The company cultivates an inclusive culture that values curiosity, creativity, and shared accountability, empowering individuals to challenge the unknown together.
Lead the investor relations team and run the weekly rhythm, including CRM reviews, KPIs, and one-on-ones with every associate.
Coach associates on calls and introductions, own network health, and ensure every client gets fitting founders on time.
Remove the team's key constraint and bring co-founders weekly numbers plus the changes you are making.
Pairs is a vetted private capital network that connects breakout founders with family offices, VCs, and strategic investors. It is a small, founder-led company with a no-ego culture and a team of around six associates in investor relations.
Set enterprise strategy for clinical pharmacology, pharmacometrics, and model-informed drug development across Recursion’s clinical portfolio.
Own dose strategy from first-in-human through registrational development, including dose escalation, optimization, and label-supporting dose justification.
Lead quantitative development approaches including population PK, PK/PD, exposure-response, PBPK, QSP, and clinical trial simulations.
Recursion is a clinical-stage TechBio company decoding biology to radically improve lives. With offices in Salt Lake City, Oxford, New York, Montréal, and London, the company values bold action, integrity, and cross-functional collaboration.
Own the commercial assessment of pipeline assets, including market sizing, target product profiles, and competitive analysis.
Drive portfolio prioritization, forecasting, and commercial recommendations to inform Go/No-Go decisions for registrational trials.
Represent Commercial in enterprise forums, operating as the strategic integrator to align stakeholders and drive execution.
Iovance Biotherapeutics is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. The company operates as an end-to-end cell therapy organization with fully owned, centralized U.S.-based manufacturing, serving thousands of cancer patients worldwide each year.
Build strong client relationships by managing complex medical issues and coordinating care globally.
Apply clinical acumen to educate and guide clients through their healthcare journey.
Collaborate with internal teams and external experts to identify innovative care options.
Private Health Management supports people with serious medical conditions, guiding them to top specialists and advanced diagnostics. The company is fully remote with employees across the United States, emphasizing a collaborative and client-focused culture.
Provide strategic leadership and operational oversight for clinical trial design, analysis, and reporting.
Build and mentor a high-performing clinical biostatistics team while driving regulatory submissions.
Partner with cross-functional teams and vendors to ensure high-quality statistical and data management support.
Enveda is a clinical-stage, AI-enabled biotech discovering medicines from nature four times faster than industry standard. With over $845M in total funding and a $2B valuation, the company is recognized as a top startup employer and has three oral medicines in the clinic.